Chen Junhao, born in 1979, is from Taiwan and holds a Bachelor of Economics degree from National Taiwan University and a Master of Finance degree from the University of Chicago.
He has been involved in the investment field for many years, previously working as an investment analyst at Morgan Stanley Asia, where he conducted in-depth research on emerging Asian markets and identified numerous investment projects with high growth potential. He then joined Kleiner Perkins Caufield & Byers as a partner, focusing on investments in the biomedical and technology sectors, successfully investing in several industry-leading companies and accumulating extensive industry connections and investment experience.
In 2025, Chen Junhao joined Kingboard Capital as Chief Investment Officer. Leveraging his profound professional knowledge and keen market insight, he leads the investment team to accurately grasp the trends in the Asian biomedical and technology startup market. He adheres to the value investing philosophy, emphasizing the long-term value assessment of investment targets and selecting high-quality investment projects. Simultaneously, he actively promotes innovative thinking within the investment team, encouraging the exploration of new investment models and areas. Through the development of scientifically sound investment strategies, he generates outstanding returns for the company's portfolio, helping Kingboard Capital stand out in a highly competitive market and become a benchmark in the biomedical and technology investment field.
